Some of these clock genes are related to the radiotherapy and chemotherapy sensitivity of GBM (Ma et al., 2020; Zhang et al., 2022; Niu et al., 2024; Xia et al., 2014; Yao et al., 2023; Zhanfeng et al., 2016). This evidence concerns the gene CLOCK and glioblastoma.